These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Efficacy and safety of captopril in low doses, alone or combined with diuretics, in the treatment of mild or moderate arterial hypertension]. Dias GC Arq Bras Cardiol; 1984 Aug; 43(2):135-7. PubMed ID: 6398043 [No Abstract] [Full Text] [Related]
43. Double-blind study on the antiproteinuric effect of captopril versus placebo in cryoglobulinaemic glomerulonephritis: a Franco-Hispano-Italian study. Nephrol Dial Transplant; 1989; 4(9):839. PubMed ID: 2516616 [No Abstract] [Full Text] [Related]
49. [Usefulness of photoplethysmography and indexes of digital pressure in Raynaud phenomenon]. Martínez S; Lozano P; Pallarés L; Juliá J; Artigues I; Plaza A; Rimbau EM; Corominas C; Gómez FT Med Clin (Barc); 1999 Sep; 113(9):327-30. PubMed ID: 10562927 [TBL] [Abstract][Full Text] [Related]
50. Phosphodiesterase inhibitors in Raynaud's phenomenon. Levien TL Ann Pharmacother; 2006; 40(7-8):1388-93. PubMed ID: 16835313 [TBL] [Abstract][Full Text] [Related]
51. [The natural course of Raynaud's phenomenon]. Clavijo F; Krahenbuhl B Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657 [TBL] [Abstract][Full Text] [Related]
52. Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial. Hu Y; Zhu J Chin Med J (Engl); 1999 Apr; 112(4):302-7. PubMed ID: 11593526 [TBL] [Abstract][Full Text] [Related]
53. [Captopril in mild or moderate systemic arterial hypertension]. Spritzer N; Wolmeister H; Spritzer TS; Maciel R Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923 [No Abstract] [Full Text] [Related]
54. [Double-blind cross-over clinical study of a new psychopharmaceutic agent: thiadipone (QM-6008), diazepam and a placebo]. Conde López V Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):409-42. PubMed ID: 7008536 [No Abstract] [Full Text] [Related]
55. [New views on therapy of Raynaud's syndrome. Preliminary note]. Giudice PA Minerva Med; 1980 May; 71(20):1459-60. PubMed ID: 7383404 [TBL] [Abstract][Full Text] [Related]
56. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo. Canty P; Valentine J J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369 [No Abstract] [Full Text] [Related]
57. [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets]. Lumholtz IB; Thorsteinsson B; Wamberg T; Lehnschau A; Hansen G; Spellerberg S; Lund B Ugeskr Laeger; 1980 Jun; 142(23):1487-90. PubMed ID: 6996251 [No Abstract] [Full Text] [Related]
58. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon. Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542 [TBL] [Abstract][Full Text] [Related]
59. [Double-blind randomized clinical study on treatment of warts with a fluorouracil-containing topical preparation (author's transl)]. Schmidt H; Jacobsen FK Z Hautkr; 1981 Jan; 56(1):41-3. PubMed ID: 7013310 [TBL] [Abstract][Full Text] [Related]
60. A double-blind, cross-over study of naproxen sodium and soluble aspirin in rheumatoid arthritis. Clarke AK; Macleod M; Steinberg VL; Wenley WG Br J Clin Pract; 1981 Apr; 35(4):143-6. PubMed ID: 7028063 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]